Interaction of delta sleep-inducing peptide and its analogues with cellular membranes: A structure-function analysis

被引:0
作者
I. I. Mikhaleva
G. T. Rikhireva
I. A. Prudchenko
I. N. Golubev
机构
[1] Russian Academy of Sciences,Shemyakin
[2] Russian Academy of Sciences,Ovchinnikov Institute of Bioorganic Chemistry
[3] State Research Institute of Organic Chemistry and Technology,Semenov Institute of Chemical Physics
来源
Russian Journal of Bioorganic Chemistry | 2006年 / 32卷
关键词
DSIP, delta sleep-inducing peptide, analogues; ESR; human thrombocytes; order parameter; plasma membranes; paramagnetic probes;
D O I
暂无
中图分类号
学科分类号
摘要
The possibility of a correlation between the membrane properties of the delta sleep-inducing peptide (DSIP) and its analogues and their biological activity in vivo was examined by a comparative study of the membrane effects of these peptides. The peptides exhibiting biological activity in vivo were shown to cause a statistically reliable disordering of lipids in thrombocyte plasma membranes similar to the effect of DSIP. The membrane effect of the D-Val2-, D-Tyr2-, and Tyr1, Pro2 analogues of DSIP had the same bimodal dose dependence characteristic of natural DSIP. Only a slight nonspecific lipid disordering was registered for Trp-Asp-Ala-Ser-Gly-Glu, a biologically inactive hexapeptide analogue. These results indicate a correlation between the biological activity of the peptides during in vivo tests and their membrane properties in vitro. The structure-function relationship was studied within the group of DSIP analogues examined in vitro. The DSIP modeling effect, especially pronounced under the action of stress factors, was suggested to be directly associated with the ability of DSIP to change the dynamic structure of biological membranes.
引用
收藏
页码:160 / 165
页数:5
相关论文
共 84 条
  • [1] Monnier M.(1977)undefined Neurosci. Lett. 6 9-13
  • [2] Dudler L.(1986)undefined Peptides 7 1165-1187
  • [3] Gaechter R.(2001)undefined Eur. J. Anaesthesiol. 18 419-422
  • [4] Schoenenberger G.A.(1999)undefined Rus. J. Bioorg. Khim. 25 292-297
  • [5] Graf M.V.(2003)undefined Biol. Membr. 20 409-418
  • [6] Kastin A.J.(1982)undefined Pharmacol. Biochem. Behav. 17 1187-1191
  • [7] Pollard B.J.(1989)undefined J. Pharmacol. 41 848-852
  • [8] Pomfrett C.J.D.(1982)undefined Bioorg. Khim. 8 900-904
  • [9] Rikhireva G.T.(1994)undefined Biochemistry 33 1323-1331
  • [10] Golubev I.N.(1998)undefined Arch. Biochem. Biophys. 349 225-235